Visiongain Publishes Antibiotic Residue Test Kit Market Report to 2031

22 February 2021
Pharma

Visiongain has published a new report on Antibiotic Residue Test Kit Market Report to 2031. According to the Visiongain analysis, the global Antibiotic Residue Test Kit market is anticipated to grow at a CAGR of XX% during the forecast period (2021-2031). The global Antibiotic Residue Test Kit market is segmented by type and end user. By type, the market is categorized as (Amphenicols, Macrolides, Tetracycline, Beta-lactams, Sulfonamides, Aminoglycosides) By end user (Food and Beverages Industry, Veterinary, Independent Laboratories Others). Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa). The report includes detailed Profiles of Leading Antibiotic Residue Test Kit Companies. PLUS COVID-19 Recovery Scenarios.

Global Antibiotic Residue Test Kit Market was valued at US$XX billion in 2021 and is projected to reach a market value of US$ XX billion by 2031. The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Advanced technology in the kits to inhibit the growth of microorganisms and increasing awareness for the benefits of antibiotic residual test kits are some of the factors driving the growth of the animal Antibiotic Residue Test Kit market.

COVID-19 Impact on the Global Antibiotic Residue Test Kit Market
The COVID-19 pandemic has hugely affected the economic and healthcare system and increased various significant challenges. The pandemic has hugely affected the manufacturer, supply, and distribution, of the various platforms. In response to the COVID-19, lockdown was initiated as a safety measure, implemented with isolation, social distancing, and quarantine. However, the pandemic allows people to take measures & aware of the health conditions and adopt proper food safety measures, which enables to drive the demand of antibiotic residue test kit market.

Market Drivers
Advanced technology in the kits to inhibit the growth of microorganisms
The Food and Drug Administration (FDA) has established safety levels of antibiotic residues in food, for the protection of consumers. The various advanced test has been developed to detect the antibiotic residues. However, the antibiotic residue test kits must meet the FDA's specifications of at least 90% sensitivity and 90% specificity within a 95% confidence interval. Mastitis is the most common disease syndrome in the dairy industry, the antibiotics such as beta-Lactams are administered in veterinary clinical practice. However, the use of advanced test kits for the dairy industry, detect antibiotic residues such as mycotoxins and other illegal additives.

Market Opportunities
Rising health consciousness and benefits of antibiotic residue test kits.
The antimicrobial substances are widely used in animal production to treat diseases and promote growth, due to which the antibiotic residues are commonly detected in animal products. The presence of antibiotic residues in food may cause serious issues among consumers. However, the growing health concerns among the population and awareness regarding the use of antibiotic residue test kits are boosting the antibiotic residue test kit market, globally.

Increasing government initiatives for food safety.
Food safety among consumers is increasing rapidly, which have a significant impact on public health as well as economic activity. The increasing government initiatives for food safety enhance the demand for the antibiotic residue test kit. The use of antibiotic residue test kits is increasing in veterinary, food & beverages, and independent laboratory. The veterinary test kits are used to detect rug resistance such as egg, muscle, and feed samples. The European Rapid Alert System for Food and Feed Operating (RASFF) is the EU’s integrated approach to food safety. The EU implemented regulations governing maximum residue levels (MRL) in certain food products of animal origin such as milk. It enables to detect of the presence of antibiotic residues in food, such as chloramphenicol, tetracycline, Beta-lactam in food related products.

Competitive Landscape
Charm Sciences, Thermo Fischer Scientific Inc., Labtek Services Ltd., DSM, Eurofins Scientific, NEOGEN Corporation, Perkin Elmer Inc., R-Biopharm AG, IDEXX Labs, SCIEX, Ring Biotechnology Co Ltd., Romer Labs Division Holding GmbH are some of the key players contributing to the growth of the global Antibiotic Residue Test Kit market. The market players are adopting new strategies to stay competitive in the global market such as new product developments, joint ventures, mergers and acquisitions, and geographical expansions.

For instance, in Feb 2020, Thermo Fisher entered partnership with Q-linea for the commercialization of ASTar. The company will have the exclusive right to offer ASTar to the market in all geographies. The partnership enables both companies to offer customers a comprehensive AST portfolio. The Thermo Fisher Sensititre Complete Automated AST System combined with Q-linea'srapid and fully automatic AST analysis increases the potential to drive the market.

March 2018, Charm Sciences, Inc. announced its sulphonamides test approval from National Conference on Interstate Milk Shipments (NCIMS). The approval of Charm Rosa sulf test to detect sulphoamides in raw milk was by the recommendation of US Food & Drug Administration (FDI).

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Rare Diseases Market Report 2021-2031

As lockdowns were imposed in all the countries, diagnosis rates went down in majority of countries during the year hitting the drug sales for some period. Although lockdown measures have been eased up in most countries by mid-year 2020, this trend is expected to continue beyond 2020, stock up of medicines by patients is likely to propel the drug sales in majority of the developed economies, which account for majority of rare diseases.

02 March 2021

Read

Visiongain Publishes Respiratory Inhalers Market Report 2021-2031

Product approval is a major milestone facing all key competitors in the respiratory inhalers market. Several strategies were implemented by key market players between 2015 and Jan 2021.

26 February 2021

Read

Visiongain Publishes Bile Duct Cancer Drugs Market Report to 2031

The global bile duct cancer drug market has been growing considerably owing to the rising incidence and prevalence rate of bile duct cancer patients worldwide, technological advancement in drug development, and healthcare spending.

22 February 2021

Read

Visiongain Publishes Big Data Analytics in Healthcare Market Report to 2031

The global Big Data Analytics in Healthcare market has been growing considerably owing to the rising technological advancement, growing investment, and cohesive government policies.

22 February 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever